We undertake committed scientific work to improve hospital and home care practices, to rigorously and independently test new products, and to promote global networks of vascular access researchers.
Patients experiencing medical treatment and needing IV catheters (including venous and arterial, central and peripheral, dialysis, chemotherapy, nutrition and cardiac care) benefit from reduced complications and a better experience of their IV treatment.
By drawing on our mix of inter-disciplinary expertise, understanding of the sector and access to international vascular access, we can help conduct needs assessment to identify gaps in clinical knowledge of professional evidence, identify potential areas of clinical practice change and develop appropriate strategies to help improve clinical workforce practice.
Our staff has professional experience in conducting these type of engagements with different clients including consulting companies, government agencies and industry bodies. The AVATAR group works to eliminate ineffective practices, and replace them with innovative solutions - saving global healthcare providers hundreds of millions of dollars per year.
Examples of current research include:
Peripherally Inserted Central Catheter OutcoMe PolyurethAne versus Endexo (PICCOMPARE trial)
Secure My Intravascular Line Effectively (The SMILE Trials)
Catheter dressings and securement (CASCADE Trial)
Flushing in Peripheral Catheters (FliP Trial)
Securing All intraVenous devices Effectively (The SAVE Trial)
One Million Global (OMG) Peripheral Intravenous Catheter Study (The OMG PIVC Study)
REDUcing the burden of dialysis Catheter ComplicaTIOns: a National approach (REDUCCTION study)